Notice of Meeting, 34772 [05-11749]
Download as PDF
<![CDATA[
34772
Federal Register / Vol. 70, No. 114 / Wednesday, June 15, 2005 / Notices
capital or other non-labor costs
associated with the document requests
are minimal. Covered entities will
already be equipped to provide written
notices (e.g., computers with word
processing programs, typewriters,
copying machines, mailing capabilities).
Most likely, only entities that already
have on-line capabilities will offer
consumers the choice to receive notices
via electronic format. As such, these
entities will already be equipped with
the computer equipment and software
necessary to disseminate the required
disclosures via electronic means.
William Blumenthal,
General Counsel.
[FR Doc. 05–11748 Filed 6–14–05; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meeting
In accordance with section 10(d) of
the Federal Advisory Committee Act (5
U.S.C., Appendix 2), announcement is
made of a Health Care Policy and
Research Special Emphasis Panel (SEP)
meeting.
A Special Emphasis Panel is a group
of experts in fields related to health care
research who are invited by the Agency
for Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10(d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b(c)(6). Grant
applications for the Limited
Competition Supplement Funds to
Centers for Education and Research on
Therapeutics (CERTs) for Developing
Effectiveness Research Methodologies
and Measures (RFA–HS–SUPP–1) are to
be reviewed and discussed at this
meeting. These discussions are likely to
reveal personal information concerning
individuals associated with the
applications. This information is
exempt from mandatory disclosure
under the above-cited statutes.
VerDate jul<14>2003
17:57 Jun 14, 2005
Jkt 205001
SEP Meeting on: The Limited
Competition Supplement Funds to
Centers for Education and Research on
Therapeutics (CERTs) for Developing
Effectiveness Research Methodologies
and Measures.
Date: July 29, 2006 (open on July 29
from 10 a.m. to 10:15 a.m. and closed
for the remainder of the meeting).
Place: John M. Eisenberg Building,
AHRQ Conference Center, 540 Gaither
Road, Rockville, Maryland 20850.
Contact Person: Anyone wishing to
obtain a roster of members, agenda or
minutes of the non-confidential portions
of this meeting should contact Mrs.
Bonnie Campbell, Committee
Management Officer, Office of
Extramural Research, Education and
Priority Populations, AHRQ, 540
Gaither Road, Room 2038, Rockville,
Maryland 20850, Telephone (301) 427–
1554.
Agenda items for this meeting are
subject to change as priorities dictate.
Dated: June 7, 2005.
Carolyn M. Clancy,
Director.
[FR Doc. 05–11749 Filed 6–13–05; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 70 FR 30120–30121,
dated May 25, 2005) is amended to
reflect the establishment of the Office of
Workforce and Career Development
within the Office of the Director,
Centers for Disease Control and
Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows:
After the mission statement for the
Office of the Chief Science Officer
(CAS), insert the following:
Office of Workforce and Career
Development (CAL). The mission of the
Office of Workforce and Career
Development (OWCD) is to improve
health outcomes by ensuring a
competent and sustainable workforce
through excellence and innovation in
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
workforce and career development. In
carrying out its mission, OWCD: (1)
Develops goals and objectives, and
provides leadership, policy formation,
scientific oversight, and guidance in
program planning and development; (2)
plans, directs, and manages CDC-wide
training programs, and internship and
fellowship programs; (3) provides
consultation, technical assistance, and
training on epidemiology, public health
informatics, and prevention
effectiveness to CDC/ATSDR, states,
other agencies, other countries, and
domestic and international
organizations; (4) develops, designs, and
implements an accredited
comprehensive strategic human
resource leadership development and
career management program for all
occupational series throughout CDC;
organizational development, career
management, employee development,
and training; (5) maximizes economies
of scale through systematic planning
and evaluation of agency-wide training
initiatives to assist CDC employees in
achieving required competencies; (6)
assists in the definition and analysis of
training needs of public health workers,
and develops and evaluates
instructional products designed to meet
those needs; (7) works with partners,
internally and externally, to develop a
strategic vision for the public health
workforce; (8) collaborates with the
Office of Strategy and Innovation (OSI)
to develop workforce goals for all of
CDC/ATSDR; (9) coordinates the
Excellence in Learning Council to
coordinate, inform, and share strategic
vision for all of CDC’s Coordinating
Centers/Coordinating Offices (CC/CO);
(10) conducts internal succession
planning, forecasting services, and
environmental scanning to ascertain
both current and future public health
workforce needs; and (11) in carrying
out the above functions, collaborates, as
appropriate, with the CDC Office of the
Director, CDC CC/COs, domestic and
international agencies and
organizations.
Office of the Director (CAL1). (1)
Provides leadership and overall
direction for OWCD; (2) develops goal
and objectives, and provides leadership,
policy formation, scientific oversight,
and guidance in program planning and
development; (3) plans, coordinates,
and develops research plans for OWCD;
(4) provides scientific leadership OWCD
research-related activities; (5) ensures
adherence to CDC and HHS sciencerelated policies, e.g., ethical conduct of
research, information security,
extramural research, data sharing; and
responds to allegations of scientific
E:\FR\FM\15JNN1.SGM
15JNN1
]]>Agencies
[Federal Register Volume 70, Number 114 (Wednesday, June 15, 2005)]
[Notices]
[Page 34772]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-11749]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Meeting
In accordance with section 10(d) of the Federal Advisory Committee
Act (5 U.S.C., Appendix 2), announcement is made of a Health Care
Policy and Research Special Emphasis Panel (SEP) meeting.
A Special Emphasis Panel is a group of experts in fields related to
health care research who are invited by the Agency for Healthcare
Research and Quality (AHRQ), and agree to be available, to conduct on
an as needed basis, scientific reviews of applications for AHRQ
support. Individual members of the Panel do not attend regularly-
scheduled meetings and do not serve for fixed terms or a long period of
time. Rather, they are asked to participate in particular review
meetings which require their type of expertise.
Substantial segments of the upcoming SEP meeting listed below will
be closed to the public in accordance with the Federal Advisory
Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C.
552b(c)(6). Grant applications for the Limited Competition Supplement
Funds to Centers for Education and Research on Therapeutics (CERTs) for
Developing Effectiveness Research Methodologies and Measures (RFA-HS-
SUPP-1) are to be reviewed and discussed at this meeting. These
discussions are likely to reveal personal information concerning
individuals associated with the applications. This information is
exempt from mandatory disclosure under the above-cited statutes.
SEP Meeting on: The Limited Competition Supplement Funds to Centers
for Education and Research on Therapeutics (CERTs) for Developing
Effectiveness Research Methodologies and Measures.
Date: July 29, 2006 (open on July 29 from 10 a.m. to 10:15 a.m. and
closed for the remainder of the meeting).
Place: John M. Eisenberg Building, AHRQ Conference Center, 540
Gaither Road, Rockville, Maryland 20850.
Contact Person: Anyone wishing to obtain a roster of members,
agenda or minutes of the non-confidential portions of this meeting
should contact Mrs. Bonnie Campbell, Committee Management Officer,
Office of Extramural Research, Education and Priority Populations,
AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone
(301) 427-1554.
Agenda items for this meeting are subject to change as priorities
dictate.
Dated: June 7, 2005.
Carolyn M. Clancy,
Director.
[FR Doc. 05-11749 Filed 6-13-05; 8:45 am]
BILLING CODE 4160-90-M
